These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 35502544)

  • 1. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
    Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
    Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination.
    Sun Z; Mai H; Xue C; Fan Z; Li J; Chen H; Huo N; Kang X; Tang C; Fang L; Zhao H; Han Y; Sun C; Peng H; Du Y; Yang J; Du N; Xu X
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
    Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
    Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
    Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3.
    Liao L; He Y; Li SJ; Zhang GG; Yu W; Yang J; Huang ZJ; Zheng CC; He QY; Li Y; Li B
    Cancer Res; 2022 Jul; 82(13):2444-2457. PubMed ID: 35507004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
    Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
    Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
    Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
    Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated N6-methyladenosine┬ámethylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3-m6A methylation inhibits the proliferation and viability of type II alveolar epithelial cells in acute lung injury by enhancing the stability and translation efficiency of Pten mRNA.
    Wang Q; Shen J; Luo S; Yuan Z; Wei S; Li Q; Yang Q; Luo Y; Zhuang L
    Respir Res; 2024 Jul; 25(1):276. PubMed ID: 39010105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.
    Yu T; Liu J; Wang Y; Chen W; Liu Z; Zhu L; Zhu W
    Biochem Biophys Res Commun; 2022 Jul; 614():9-16. PubMed ID: 35567945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.